DS
DSP Nifty Healthcare Index Fund Direct Growth
Latest NAV
+12.67% 1Y
Sign In to Add to Portfolio
Benchmark: NIFTY Healthcare TRI
Expense ratio
0.41%
AUM
₹25 Cr
Min SIP
₹100
Min lump sum
₹100
1Y
+12.67%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
Jun 2025
Where the NAV sits & how risky it is
₹11.34
52-week range
at 68%
₹11.34
Low 29 Jan 2026₹9.79
High 31 Aug 2026₹12.06
Risk level
Very High
Low
Very high
NAV history
23 Jun 2025
Since inception
05 Oct 2026
Returns by period
1W
-3.96%
1M
-3.47%
3M
+0.43%
6M
+14.71%
1Y
+12.67%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 99.43%
Cash & other 0.57%
Sector split
Country split
Top 5 hold 49.6%
Top 10 hold 75.9%
20 equity holdings
Equity holdings
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
18.27%
|
+4.97% |
| 2 | Divis Laboratories
INE361B01024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
8.12%
|
+3.85% |
| 3 | Apollo Hospitals
INE437A01024 |
Healthcare Medical Care Facilities |
India |
8.07%
|
+20.67% |
| 4 | Dr Reddys Laboratories
INE089A01031 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
7.62%
|
+0.02% |
| 5 | Cipla
INE059A01026 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
7.56%
|
-8.03% |
| 6 | Max Healthcare Institute
INE027H01010 |
Healthcare Medical Care Facilities |
India |
6.89%
|
-3.35% |
| 7 | Lupin
INE326A01037 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.27%
|
+7.76% |
| 8 | Laurus Labs
INE947Q01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.08%
|
+25.17% |
| 9 | Fortis Healthcare
INE061F01013 |
Healthcare Medical Care Facilities |
India |
4.64%
|
+11.88% |
| 10 | Torrent Pharmaceuticals
INE685A01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
4.42%
|
+16.93% |
About this scheme
The investment objective of the Scheme is to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
Fund manager(s): Anil Ghelani, Diipesh Shah, Neha Rathi
Exit load: No charges for withdrawal
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
20 Jun 2025
Lump-sum min
₹100
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
SBI Silver ETF FoF Direct Growth
1▲ 37.7 pts ahead of this fund
Kotak Silver ETF FoF Direct Growth
2▲ 36.8 pts ahead of this fund
Axis Silver FoF Direct Growth
3▲ 36.2 pts ahead of this fund
ICICI Prudential Strategic Metal and Energy Equity FoF Direct Growth
4▲ 36.2 pts ahead of this fund
DSP Silver ETF FoF Direct Growth
5▲ 36.0 pts ahead of this fund
Zerodha Silver ETF FoF Direct Growth
6▲ 36.0 pts ahead of this fund